Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 2
1994 1
1995 1
1997 2
1998 1
1999 1
2000 13
2001 9
2002 10
2003 3
2004 5
2005 5
2006 1
2007 10
2008 15
2009 21
2010 19
2011 19
2012 31
2013 25
2014 13
2015 9
2016 8
2017 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

197 results

Results by year

Filters applied: . Clear all
Page 1
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial.
Martin M, Holmes FA, Ejlertsen B, Delaloge S, Moy B, Iwata H, von Minckwitz G, Chia SKL, Mansi J, Barrios CH, Gnant M, Tomašević Z, Denduluri N, Šeparović R, Gokmen E, Bashford A, Ruiz Borrego M, Kim SB, Jakobsen EH, Ciceniene A, Inoue K, Overkamp F, Heijns JB, Armstrong AC, Link JS, Joy AA, Bryce R, Wong A, Moran S, Yao B, Xu F, Auerbach A, Buyse M, Chan A; ExteNET Study Group. Martin M, et al. Lancet Oncol. 2017 Dec;18(12):1688-1700. doi: 10.1016/S1470-2045(17)30717-9. Epub 2017 Nov 13. Lancet Oncol. 2017. PMID: 29146401 Clinical Trial.
Renal cell cancer: overview of the current therapeutic landscape.
Erman M, Benekli M, Basaran M, Bavbek S, Buyukberber S, Coskun U, Demir G, Karabulut B, Oksuzoglu B, Ozkan M, Sevinc A, Yalcin S. Erman M, et al. Among authors: buyukberber s. Expert Rev Anticancer Ther. 2016 Sep;16(9):955-68. doi: 10.1080/14737140.2016.1222908. Epub 2016 Aug 24. Expert Rev Anticancer Ther. 2016. PMID: 27548347 Review.
Time is up!
Sevinc A, Camci C, Buyukberber S. Sevinc A, et al. Among authors: buyukberber s. Acta Clin Belg. 2005 Mar-Apr;60(2):106-7. doi: 10.1179/acb.2005.020. Acta Clin Belg. 2005. PMID: 16082998 No abstract available.
Crizotinib-induced toxicity in an experimental rat model.
Gumusay O, Esendagli-Yilmaz G, Uner A, Cetin B, Buyukberber S, Benekli M, Ilhan MN, Coskun U, Gulbahar O, Ozet A. Gumusay O, et al. Among authors: buyukberber s. Wien Klin Wochenschr. 2016 Jun;128(11-12):435-41. doi: 10.1007/s00508-016-0984-y. Epub 2016 Mar 14. Wien Klin Wochenschr. 2016. PMID: 26975454
Intrasellar plasmacytoma: an unusual presentation of multiple myeloma.
Yaman E, Benekli M, Coskun U, Sezer K, Ozturk B, Kaya AO, Yildiz R, Uluoglu O, Buyukberber S. Yaman E, et al. Among authors: buyukberber s. Acta Neurochir (Wien). 2008 Sep;150(9):921-4; discussion 924. doi: 10.1007/s00701-008-0012-8. Epub 2008 Aug 23. Acta Neurochir (Wien). 2008. PMID: 18726062 Review.
Coexistence Hodgkin's lymphoma and colonic adenocarcinoma: a case report.
Demirci U, Büyükberber S, Yilmaz G, Oztürk B, Akyürek N, Yildiz R, Tonyali O, Coşkun U, Benekli M. Demirci U, et al. Among authors: buyukberber s. Med Oncol. 2010 Mar;27(1):62-4. doi: 10.1007/s12032-009-9172-5. Epub 2009 Feb 10. Med Oncol. 2010. PMID: 19205930
197 results